Exposure-dependent increases in IL-1β, substance P, CTGF, and tendinosis in flexor digitorum tendons with upper extremity repetitive strain injury

Journal of Orthopaedic Research

Volumn 28, Issue 3, 2010, Pages 298-307

  Fedorczyk, Jane M ^a   Barr, Ann E ^b   Rani, Shobha ^c   Gao, Helen G ^c   Amin, Mamta ^d   Amin, Shreya ^d   Litvin, Judith ^c   Barbe, Mary F ^b,c,d  

^a DREXEL UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TEMPLE UNIVERSITY   (United States)

Author keywords

CTGF; Cytokines; Flexor digitorum tendon; Inflammation; PLF; Repetitive task; WMSD

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; INTERLEUKIN 1BETA; PERIOSTIN LIKE FACTOR; SUBSTANCE P; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARM MUSCLE; ARTICLE; CELL INVASION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; FEMALE; GRIP STRENGTH; HISTOPATHOLOGY; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPETITIVE STRAIN INJURY; TASK PERFORMANCE; TENDINITIS;

ANIMALS; CONNECTIVE TISSUE GROWTH FACTOR; CUMULATIVE TRAUMA DISORDERS; DISEASE PROGRESSION; FEMALE; FIBROBLASTS; FORELIMB; HAND STRENGTH; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1BETA; MACROPHAGES; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE P; TENDINOPATHY; TENDONS; TIME FACTORS;

EID: 73949113573     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20984     Document Type: Article

References (44)

1. Ranney D, Well R, Moore A. 1995. Upper limb musculoskeletal disorders in highly repetitive industries: precise anatomical physical findings. Ergonomics 38:1408-1423.
2. Bystrom S, Hall C, Welander T, et al. 1995. Clinical disorders and pressure-pain threshold of the forearm and hand among automobile assembly line workers. J Hand Surg (Br) 20:782-790.
3. Gerr F, Marcus M, Ensor C, et al. 2002. A prospective study of computer users: I. Study of design and incidence of musculoskeletal symptoms and design. Am J Ind Med 41:221-235.
4. Kurppa K, Viikari-Juntura E, Kuosma E, et al. 1991. Incidence of tenosynovitis or peritendinitis and epicondylitis in a meat-processing factory. Scand J Work Environ Health 17:32-37.
5. Silverstein BA, Fine LJ, Armstrong TJ. 1986. Hand wrist cumulative trauma disorders in industry. Br J Ind Med 43:779-784.
6. Latko WA, Armstrong TJ, Franzblau A, et al. 1999. Cross-sectional study of the relationship between repetitive work and the prevalence of upper limb musculoskeletal disorders. Am J Ind Med 36:248-259.
7. Ljung B-O, Forsgren S, Fridén J. 1999. Substance P and calcitonin gene-related peptide expression at the extensor carpi radialis brevis muscle origin: implications for the etiology of tennis elbow. J Orthop Res 17:554-559.
8. Alfredson H, Lorentzon R. 2002. Chronic tendon pain: no signs of chemical inflammation but high concentrations of the neurotransmitter glutamate. Implications for treatment? Curr Drug Targets 3:43-54.
9. Alfredson H, Ljung B-O, Thorsen K, et al. 2000. In vivo investigation of ECRB tendons with microdialysis technique-no signs of inflammation but high amounts of glutamate in tennis elbow. Acta Orthop Scand 71:475-479.
10. Freeland AE, Tucci MA, Barbieri RA, et al. 2002. Biochemical evaluation of serum and flexor tenosynovium in carpal tunnel syndrome. Microsurgery 22:378-385.
11. Hirata H, Nagakura T, Tsujii M, et al. 2004. The relationship of VEGF and PGE2 expression to extracellular matrix remodelling of the tenosynovium in the carpal tunnel syndrome. J Pathol 204:605-612.
12. Brain SD, Cox HM. 2006. Neuropeptides and their receptors:innovative science providing novel therapeutic targets. Br J Pharmacol 147:S202-S211.
13. Ljung B, Alfredson H, Forsgren S. 2004. Neurokinin 1-receptors and sensory neuropeptides in tendon insertions at the medial and lateral epicondyles of the humerus Studies on tennis elbow and medial epicondylalgia. J Orthop Res 22:321-327.
14. Messner K, Wei Y, Andersson B, et al. 1999. Rat model of Achilles tendon disorder. A pilot study. Cells Tissues Organs 165:30-39.
15. Andersson G, Danielson P, Alfredson H, et al. 2008. Presence of substance P and the neurokinin-1 receptor in tenocytes of the human Achilles tendon. Regul Pept 150:81-87.
16. Ettema AM, Amadio PC, Zhao C, et al. 2004. A histological and immunohistochemical study of the subsynovial connective tissue in idiopathic carpal tunnel syndrome. J Bone Joint Surg Am 86-A:1458-1466.
17. Nakama LH, King KB, Abrahamsson S, et al. 2006. VEGF, VEGFR-1, and CTGF cell densities in tendon are increased with cyclical loading: An in vivo tendinopathy model. J Orthop Res 24:393-400.
18. Soslowsky LJ, Thomopoulos S, Esmail A, et al. 2002. Rotator cuff tendinosis in an animal model:role of extrinsic and overuse factors. Ann Biomed Eng 30:1057-1063.
19. Barbe MF, Barr AE, Gorzelany I, et al. 2003. Chronic repetitive reaching and grasping results in decreased motor performance and widespread tissue responses in a rat model of MSD. J Orthop Res 21:167-176.
20. Barbe MF, Elliott MB, Abdelmagid SM, et al. 2008. Serum and tissue cytokines and chemokines increase with repetitive upper extremity tasks. J Orthop Res 26:1320-1326.
21. Al-Shatti T, Barr AE, Safadi FF, et al. 2005. Increase in inflammatory cytokines in median nerves in a rat model of repetitive motion injury. J Neuroimmunol 167:13-22.
22. Clark BD, Al-Shatti TA, Barr AE, et al. 2004. Performance of a high-repetition, high-force task induces carpal tunnel syndrome in rats. J Orthop Sports Phys Ther 34:244-253.
23. Elliott MB, Barr AE, Kietrys DM, et al. 2008. Peripheral neuritis and increased spinal cord neurochemicals are induced in a model of repetitive motion injury with low force and repetition exposure. Brain Res 1218:103-113.
24. Rani S, Barbe MF, Barr AE, et al. 2009. Periostin-like-factor and Periostin in an animal model of work-related musculoskeletal disorder. Bone 44:502-512.
25. Kehl LJ, Hamamoto DT, Wacnik PW, et al. 2003. A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain. Pain 103:175-186.
26. Wacnik PW, Kehl LJ, Trempe TM, et al. 2003. Tumor implantation in mouse humerus evokes movement-related hyperalgesia exceeding that evoked by intramuscular carrageenan. Pain 101:175-186.
27. Cook JL, Feller JA, Bonar SF, et al. 2004. Abnormal tenocyte morphology is more prevalent than collagen disruption in asymptomatic athletes' patellar tendons. J Orthop Res 22:334-338.
28. Soslowsky LJ, Thomopoulos S, Esmai A, et al. 2002. Rotator cuff tendinosis in an animal model: role of extrinsic and overuse factors. Ann Biomed Eng 30:1057-1063.
29. Rani S, Barbe MF, Barr AE, et al. 2009. Induction of Periostin-Like- Factor and Periostin in Forearm Muscle, Tendon and Nerve in an Animal Model of Work-Related Musculoskeletal Disorder. J Histochem Cytochem. 2009. [Epub ahead of print] PMID: 19620321.
30. Ackermann PW, Li J, Lundeberg T, et al. 2003. Neuronal plasticity in relation to nociception and healing of rat achilles tendon. J Orthop Res 21:432-441.
31. Berglund M, Hart DA, Wiig M. 2007. The inflammatory response and hyaluronan synthases in the rabbit flexor tendon and tendon sheath following injury. J Hand Surg Eur 32:581-587.
32. Archambault JM, Hart DA, Herzog W. 2001. Response of rabbit Achilles tendon to chronic repetitive loading. Connect Tissue Res 42:13-23.
33. Uchio Y, Ochi M, Ryoke K, et al. 2002. Expression of neuropeptides and cytokines at the extensor carpi raidalis brevis muscle origin. J Shoulder Elbow Surg 11:570-575.
34. Rupp EA, Cameron PM, Ranawat CS, et al. 1986. Specific bioactivities of monocyte-derived interleukin 1 alpha and interleukin 1 beta are similar to each other on cultured murine thymocytes and on cultured human connective tissue cells. J Clin Invest 78:836-839.
35. Marsolais D, Cote CH, Frenette J. 2001. Neutrophils and macrophages accumulate sequentially following Achilles tendon injury. J Orthop Res 19:1203-1209.
36. Tsuzaki M, Guyton G, Garrett W, et al. 2003. IL-1 beta induces COX2, MMP-1, -3 and -13, ADAMTS-4, IL-1 beta and IL-6 in human tendon cells. J Orthop Res 21:256-264.
37. Archambault J, Tsuzaki M, Herzog W, et al. 2002. Stretch and interleukin-1beta induce matrix metalloproteinases in rabbit tendon cells in vitro. J Orthop Res 20:36-39.
38. Andersson G, Danielson P, Alfredson H, et al. 2007. Nerve-related characteristics of ventral paratendinous tissue in chronic Achilles tendinosis. Knee Surg Sports Traumatol Arthrosc 15:1272-1279.
39. Reynier-Rebuffel A, Mathiau P, Callebert J, et al. 1994. Substance P, calcitonin gene-related peptide, and capsaicin release serotonin from cerebrovascular mast cells. Am J Physiol 267:1421-1429.
40. Lai J, Ho W, Zhan G, et al. 2001. Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes. Proc Natl Acad Sci USA 98:3970-3975.
41. Weinstein J. 1991. Neurogenic and nonneurogenic pain and inflammatory mediators. Orthop Clin North Am 22:235-246.
42. Hua X, Back S, Tam E. 1996. Substance P enhances electrical field stimulation-induced mast cell degranulation in rat trachea. Am J Physiol 270:985-991.
43. Morioka N, Takeda K, Kumagai K, et al. 2002. Interleukin-1beta-induced substance P release from rat cultured primary afferent neurons driven by two phospholipase A2 enzymes: secretory type IIA and cytosolic type IV. J Neurochem 80:989-997.
44. Nilsson J, von Euler AM, Dalsgaard CJ. 1985. Stimulation of connective tissue cell growth by substance P and substance K. Nature 315:61-63.